Puvan Tharmanathan

University of York — United Kingdom

Economics, Econometrics and Finance · Social Sciences

17h-index2.4kcitations67works6.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(14), Rheumatoid Arthritis Research and Therapies(10), Meta-analysis and systematic reviews(8), Statistical Methods in Clinical Trials(8), Osteoarthritis Treatment and Mechanisms(4)

Publications67 total

The Cost-Effectiveness of Collagenase Injection Versus Limited Fasciectomy for Moderate Dupuytren’s Contracture: An Economic Evaluation of the Dupuytren’s Interventions Surgery Versus Collagenase Trial and a Decision Analytical Model
Value in Health·2025· 1 citedOpen Access
Standardising management of consent withdrawal and other clinical trial participation changes: The UKCRC Registered Clinical Trials Unit Network’s PeRSEVERE project
Clinical Trials·2025Open Access
Value-adaptive clinical trial designs for efficient delivery of publicly funded trials - a discussion of methods, case studies, opportunities and challenges
BMC Medical Research Methodology·2025· 1 citedOpen Access
Collagenase Injection versus Limited Fasciectomy for Dupuytren’s Contracture
New England Journal of Medicine·2024· 15 citedOpen Access
Pain Reduction With Oral Methotrexate in Knee Osteoarthritis
Annals of Internal Medicine·2024· 30 citedOpen Access
The performance of a Bayesian value-based sequential clinical trial design in the presence of an equivocal cost-effectiveness signal: evidence from the HERO trial
BMC Medical Research Methodology·2024· 1 citedOpen Access
Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia—a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial
Trials·2024· 2 citedOpen Access
Collagenase injection versus limited fasciectomy surgery to treat Dupuytren’s contracture in adult patients in the UK: DISC, a non-inferiority RCT and economic evaluation
Health Technology Assessment·2024· 4 citedOpen Access
Study within a trial 119: The effectiveness of a thank you card to improve trial follow up; a randomised study within a trial
Research Methods in Medicine & Health Sciences·2024· 1 citedOpen Access
Reverse shoulder arthroplasty versus hemiarthroplasty versus non-surgical treatment for older adults with acute 3- or 4-part fractures of the proximal humerus: study protocol for a randomised controlled trial (PROFHER-2: PROximal Fracture of Humerus Evaluation by Randomisation – Trial Number 2)
Trials·2023· 20 citedOpen Access
Reverse Shoulder Arthroplasty versus Hemiarthroplasty versus Non-Surgical treatment for older adults with acute 3- or 4-part fractures of the proximal humerus: study protocol for a randomised controlled trial (PROFHER-2: PROximal Fracture of Humerus Evaluation by Randomisation – Trial Number 2)
2023· 1 citedOpen Access
Researchers’ experiences of pharmacy involvement: a UK cross-sectional survey
Journal of Pharmaceutical Health Services Research·2022
Can learnings from the COVID-19 pandemic improve trial conduct post-pandemic? A case study of strategies used by the DISC trial
Research Methods in Medicine & Health Sciences·2022· 4 citedOpen Access
174 The EXTEND Trial: EXTENDed Antibiotics to Improve Outcomes in Patients with Complicated Intra-Abdominal Infection
British journal of surgery·2022Open Access
Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial
European Respiratory Journal·2022· 45 citedOpen Access
Staff training to improve participant recruitment into surgical randomised controlled trials: A feasibility study within a trial (SWAT) across four host trials simultaneously
Research Methods in Medicine & Health Sciences·2022· 13 citedOpen Access
P10 Biomarker Driven Antifungal Stewardship in Acute Leukaemia (BioDriveAFS)—a multicentre randomized controlled trial to assess clinical and cost effectiveness
JAC-Antimicrobial Resistance·2022Open Access
Report for the EcoNomics of Adaptive Clinical Trials (ENACT) project : Application of a Bayesian Value-Based Sequential Model of a Clinical Trial to the CACTUS and HERO Case Studies (with Guidance Material for Clinical Trials Units)
White Rose Research Online (University of Leeds, The University of Sheffield, University of York)·2021· 2 cited
Dupuytren’s interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial
Trials·2021· 15 citedOpen Access
Cost-effectiveness of hydroxychloroquine versus placebo for hand osteoarthritis: economic evaluation of the HERO trial
F1000Research·2021· 6 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

David Torgerson(20), Catherine Hewitt(17), Catherine Arundel(16), Ada Keding(14), Philip G. Conaghan(9), Belén Corbacho(9), Simon Gilbody(8), Elizabeth Littlewood(8), Gwen Brierley(8), Peter Bower(8), Cindy Cooper(8), Phil Andersen(8), Sarah Ronaldson(8), Fraser Birrell(8), Michael Doherty(8), Fiona E. Watt(8), David L. Scott(8), Charlie Welch(8), Michael Barkham(7), Linda Gask(7)